Literature DB >> 559102

Cell-free coupling of influenza virus RNA transcription and translation.

J Content, L D Wit, M Horisberger.   

Abstract

A cell-free coupled system for the transcription and translation of fowl plague virus RNA is described. The system utilizes a new nuclease-preincubated rabbit reticulocyte lysate that has a high sensitivity to exogenous mRNA and a very low level of nuclease activity. Translation of the viral proteins in the coupled system is strictly dependent upon the viral transcriptase activity. In the coupled system the optimal concentration of magnesium is intermediate between the optimum for transcription and that for translation. Translation of the viral proteins seems faithful. The products represent the major viral peptides M and NP and two peptides with the same electrophoretic mobility as HA and P2. Viron NA is not resolved in the kind of polyacrylamide gels described. Proteins M and NP were immunoprecipitable with monospecific antisera. It is concluded that the virion-associated RNA polymerase transcribes the negative-stranded segments of the viral genome coding for these major structural proteins into fully functional mRNA's.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 559102      PMCID: PMC515713     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  Influenza viral mRNA contains internal N6-methyladenosine and 5'-terminal 7-methylguanosine in cap structures.

Authors:  R M Krug; M A Morgan; A J Shatkin
Journal:  J Virol       Date:  1976-10       Impact factor: 5.103

2.  Influenza virion RNA-dependent RNA polymerase: stimulation by guanosine and related compounds.

Authors:  D McGeoch; N Kitron
Journal:  J Virol       Date:  1975-04       Impact factor: 5.103

3.  Studies on the in vitro transcription and translation of vesicular stomatitis virus mRNA.

Authors:  M Breindl; J J Holland
Journal:  Virology       Date:  1976-08       Impact factor: 3.616

4.  RNA synthesis by ribonucleoprotein-polymerase complexes isolated from influenza virus.

Authors:  O M Rochovansky
Journal:  Virology       Date:  1976-09       Impact factor: 3.616

5.  In vitro translation of influenza virus messenger RNAs.

Authors:  M B Richey; P Palese
Journal:  Virology       Date:  1976-07-15       Impact factor: 3.616

6.  Influenza viral messenger RNA.

Authors:  P R Etkind; R M Krug
Journal:  Virology       Date:  1974-11       Impact factor: 3.616

7.  Efficient translation of tobacco mosaic virus RNA and rabbit globin 9S RNA in a cell-free system from commercial wheat germ.

Authors:  B E Roberts; B M Paterson
Journal:  Proc Natl Acad Sci U S A       Date:  1973-08       Impact factor: 11.205

8.  An efficient mRNA-dependent translation system from reticulocyte lysates.

Authors:  H R Pelham; R J Jackson
Journal:  Eur J Biochem       Date:  1976-08-01

9.  The in vitro stimulation of the influenza transcriptase by ribosomes.

Authors:  M Horisberger
Journal:  FEBS Lett       Date:  1976-03-15       Impact factor: 4.124

10.  Cell-free translation of influenza virus mRNA.

Authors:  J Content
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

View more
  4 in total

1.  Globin mRNAs are primers for the transcription of influenza viral RNA in vitro.

Authors:  M Bouloy; S J Plotch; R M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

2.  The coupling of transcription from influenza virions to translation in vitro.

Authors:  P D Minor; N J Dimmock
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

3.  Peptide mapping characterization of viral proteins generated in a cell-free coupled system for the transcription and translation of influenza virus mRNA.

Authors:  J Content; L De Wit; M A Horisberger
Journal:  J Virol       Date:  1978-06       Impact factor: 5.103

4.  Infection of chicken erythrocytes with influenza and other viruses.

Authors:  R F Cook; R J Avery; N J Dimmock
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.